Gornitzky GNY has leading practice in the life sciences fields (medical devices, pharmaceuticals, and digital health). We advise founders, companies, incubators, investors, funds, research institutions, and medical centers, as well as multinational companies and the largest insurers in the world.
Our clients in the medical devices sector develop solutions for intensive care complications, disease detection, heart-related diseases, solutions for measurement problems related to drugs, nutrition, and more.
We represent dozens of companies developing drugs for orphan diseases of all types, cancer, skin diseases, and cosmetic purposes.
Additionally, our firm is recognized as one of the leading firms in Israel in the field of digital health. We advise on the intersection of software, artificial intelligence (AI), deep learning (DL), education, and medicine, big data, telemedicine (online healthcare), general health services, and wearable technology.
We represent our clients in complex transactions involving:
- Licensing and development agreements;
- Clinical trial agreements;
- Agreements with clinical research organizations (CROs);
- Agreements with clinical and regulatory consultants;
- Supply and manufacturing agreements;
- Commercialization agreements, including distribution agreements, resale agreements, and sub-licensing.
These transactions require an understanding of market-related issues and standards related to liability, privacy, cybersecurity, insurance, and treatment quality. Our firm is considered at the forefront in these standards.
Our understanding of the boundaries of liability and the inherent risks in these matters allows us to provide comprehensive advice on a wide range of corporate and financial challenges facing companies in this field, including:
- Financing and investment from venture capital funds, institutional entities, government offices, authorities, and private investors;
- GDPR (General Data Protection Regulation) and privacy protection and databases according to Israeli privacy protection laws;
- Employment and consultancy agreements, equity compensation plans, compensation policies, and benefits for directors, senior officers, other employees, and consultants;
- General and commercial legal advice for companies and corporations;
- Exit strategies, including asset sales, exclusive licensing agreements, initial public offerings (IPOs), follow-on offerings, and mergers and acquisitions.
